Claims
- 1. A compound of formula:
- R.sup.1 --Z--CHR.sup.2 --A (I)
- wherein:
- A is
- --BY.sup.1 Y.sup.2,
- Y.sup.1 and Y.sup.2 are independently
- --OH;
- Y.sup.1 and Y.sup.2 can be taken together to form:
- a) a cyclic boron ester where said chain or ring contains from 2 to 20 carbon atoms and, from 0-3 heteroatoms which can be N, S, or O,
- b) a cyclic boron amide where said chain or ring contains from 2 to 20 carbon atoms and,from 0-3 heteroatoms which can be N, S, or O,
- c) a cyclic boron amide-ester where said chain or ring contains from 2 to 20 carbon atoms and from 0-3 heteroatoms which can be N, S, or O;
- Z is
- a)--(CH.sub.2).sub.m CONR.sup.8 --,
- b)--(CH.sub.2).sub.m CSNR.sup.8 --,
- c)--(CH.sub.2).sub.m SO.sub.2 NR.sup.8 --,
- d)--(CH.sub.2).sub.m CO.sub.2 --,
- e)--(CH.sub.2).sub.m C(S)O--, or
- f)--(CH.sub.2).sub.m SO.sub.2 O--;
- R.sup.1 is
- a) heteroaryl, wherein heteroaryl is an unsubstituted, monosubstituted or disubstituted:
- i) quinolinyl,
- ii) isoquinolinyl,
- iii) benzopyranyl,
- iv) benzothiophenyl,
- v) benzofuranyl,
- vi) 5,6,7,8-tetrahydroquinolinyl,
- vii) 5,6,7,8-tetrahydroisoquinolinyl,
- and wherein the substituents are members selected from the group consisting of halo (F, Cl, Br, I), --CN, C.sub.1 -C.sub.10 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.2 -C.sub.10 -alkenyl, C.sub.2 -C.sub.10 -alkynyl, R.sup.8, --OR.sup.8, --NO.sub.2, --CF.sub.3, --S(O).sub.r R.sup.7, --NR.sup.8 R.sup.9, --COR.sup.8, --CO.sub.2 R.sup.8, --CONHR.sup.8, NR.sup.8 COR.sup.9, NR.sup.8 CO.sub.2 R.sup.9, ##STR157## wherein J is N or C and K, L, M and Q are independently selected at each occurrence from the group consisting of N, CR.sup.13, S or O, provided that:
- i) there may be only one S or O present in the ring at a time;
- ii) there may only be 1-2N present when there is an O or S present;
- iii) there may be only 1-4N present; ##STR158## wherein W, R, T, U and V are selected from the group consisting of: CR.sup.13 or N, provided that there be no less than 1 and no more than 3N present; ##STR159## is as defined above; ##STR160## is as defined above; ##STR161## wherein G is O, S, or NP, where P is an amine protecting group selected from the group consisting of: --R.sup.3, --C(.dbd.O)R.sup.3, --SO.sub.2 R.sup.3, --C(.dbd.O)OR.sup.3); ##STR162## wherein G is O, S, or NP, where P is an amine protecting group selected from the group consisting of: --R.sup.3, --C(.dbd.O)R.sup.3, --SO.sub.2 R.sup.3, --C(.dbd.O)OR.sup.3);
- R.sup.2 is
- a) --(C1-C12 alkyl)--X,
- b) --(C2-C12 alkenyl)--X, or ##STR163## X is a) halogen (F, Cl, Br, I),
- b) --CN,
- c) --NO.sub.2,
- d) --CF.sub.3,
- e) --S(O).sub.r R.sup.14,
- f) --NHR.sup.14
- g) --NHS(O).sub.r R.sup.14,
- h) --NHC(NH)H,
- i) --NHC(NH)NHOH,
- j) --NHC(NH)NHCN,
- k) --NHC(NH)NHR.sup.14,
- l) --NHC(NH)NHCOR.sup.14,
- m) --C(NH)NHR.sup.14,
- n) --C(NH)NHCOR.sup.14,
- o) --C(O)NHR.sup.14,
- p) --C(O)NHC(O)R.sup.14,
- q) --C(O)OR.sup.14,
- r) --OR.sup.14,
- s) --OC(O)R.sup.14,
- t) --OC(O)OR.sup.14,
- u) --OC(O)NHR.sup.14,
- v) --OC(O)NHC(O)R.sup.14,
- w) --SC(.dbd.NH)NHR.sup.14, or
- x) --SC(.dbd.NH)NHC(.dbd.O)R.sup.14 ;
- R.sup.3 is
- a) hydrogen,
- b) C.sub.1 -C.sub.8 alkyl,
- c) --(C.sub.1 -C.sub.4 alkyl)-aryl,
- d) C.sub.5 -C.sub.7 cycloalkyl, or
- e) phenyl;
- R.sup.5 and R.sup.6 are hydrogen or when taken together form a six membered aromatic ring optionally substituted with one, two or three substituents selected from the group consisting of halo (F, Cl, Br, I), --CN, C.sub.1 -C.sub.10 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.2 -C.sub.10 -alkenyl, C.sub.2 -C.sub.10 -alkynyl, --OR.sup.8, --NO.sub.2, --CF.sub.3, --S(O).sub.r R.sup.7, --NR.sup.8 R.sup.9, --COR.sup.8, --CO.sub.2 R.sup.8, --CONR.sup.8 R.sup.9, phenyl, benzyl, phenylethyl;
- R.sup.7 is
- a) phenyl,
- b) C.sub.1 -C.sub.8 -alkyl,
- c) C.sub.1 -C.sub.4 -alkoxy,
- d) --CF.sub.3, or
- e) benzyl;
- R.sup.8 and R.sup.9 are independently
- a) H, ##STR164## c) C.sub.3 -C.sub.7 cycloalkyl, d) C.sub.1 -C.sub.8 -alkyl, or
- R.sup.11 is
- a) halo (F, Cl, Br, I),
- b) --CN,
- c) C.sub.1 -C.sub.10 -alkyl,
- d) C.sub.3 -C.sub.8 -cycloalkyl,
- e) C.sub.2 -C.sub.10 -alkenyl,
- f) C.sub.2 -C.sub.10 -alkynyl,
- g) --OR.sup.8,
- h) --NO.sub.2,
- i) --CF.sub.3,
- j) --S(O).sub.r R.sup.7,
- k) --NR.sup.8 R.sup.9,
- m) --CO.sub.2 R.sup.8,
- l) --COR.sup.9,
- n) --CONR.sup.8 R.sup.9, or
- o) H
- R.sup.12 is
- H, C.sub.1 -C.sub.4 alkyl, phenyl, benzyl, --COR.sup.7, or --S(O).sub.r R.sup.7 ;
- R.sup.13 is
- H, halogen (F, Cl, Br, I), (C.sub.1 -C.sub.8)alkyl, (C.sub.1 -C.sub.6)-perfluoroalkyl, --(CH.sub.2).sub.r -D, C.sub.3 -C.sub.8 cycloalkyl, C.sub.2 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -alkynyl, methylenedioxy, --(CH.sub.2).sub.w --OR.sup.8, --(CH.sub.2).sub.w NC, --(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NO.sub.2, --(CH.sub.2).sub.w CF.sub.3, --(CH.sub.2).sub.w S(O).sub.r R.sup.7, --(CH.sub.2).sub.w NR.sup.8 R.sup.9, --(CH.sub.2).sub.w COR.sup.8, --(CH.sub.2).sub.w CO.sub.2 R.sup.8, --(CH.sub.2).sub.w CONR.sup.8 R.sup.9, --(CH.sub.2).sub.w SO.sub.2 NH--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH.sub.2, --(CH.sub.2).sub.w SO.sub.2 NH--CO--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH--CO.sub.2 -(C.sub.1 -C.sub.6)alkyl, --(CH.sub.2).sub.w SO.sub.2 NH, --(CH.sub.2).sub.w NHSO.sub.2 --(CH.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-perfluoroalkyl, --(CH.sub.2).sub.w NHSO.sub.2 -phenyl, --(CH.sub.2).sub.w NHSO.sub.2 -perfluorophenyl, --(CH.sub.2).sub.w CN.sub.4 H, --O(C.dbd.O)--(C.sub.1 -C.sub.5 alkyl), --O(CH.sub.2).sub.w CN, --NH(CH.sub.2).sub.w CN, --S(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO-(phenyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO.sub.2 -(phenyl), --(CH.sub.2).sub.u phenyl wherein the phenyl contains 0-3 substituents selected from R.sup.18, --S--(CH.sub.2).sub.u phenyl wherein the phenyl contains 0-3 substituents selected from R.sup.18, or --O--(CH.sub.2).sub.u phenyl wherein the phenyl contains 0-3 substituents selected from R.sup.18 ;
- R.sup.14 is
- a) --H,
- b) --CF.sub.3
- c) --C.sub.1 -C.sub.4 alkyl,
- d) --(CH.sub.2).sub.q -aryl, wherein aryl is phenyl, biphenyl, naphthyl, or fluorenyl unsubstituted or substituted with one to three substituents selected from the group consisting of:
- halogen (F, Cl, Br, I),
- --CF.sub.3,
- --(C.sub.1 -C.sub.4 alkyl),
- --(CH.sub.2).sub.x R.sup.15,
- --(CH.sub.2).sub.x CO(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x C(O)O(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x C(O)N[(CH.sub.2).sub.y R.sup.15 ] [(CH.sub.2).sub.y R.sup.16 ],
- --methylenedioxy,
- --(C.sub.1 -C.sub.4 alkoxy),
- --(CH.sub.2).sub.x O(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x OCO(CH.sub.2).sub.y R.sup.15,
- --(CH.sub.2).sub.x OC(O)O(CH.sub.2).sub.y R.sup.15,
- --(C.sub.2).sub.x OC(O)N[(CH.sub.2).sub.y R.sup.15 ] [(CH.sub.2).sub.y R.sup.16 ],
- --(CH.sub.2).sub.x OC(O)N[(CH.sub.2).sub.y R.sup.15 ] [CO(CH.sub.2).sub.y R.sup.16 ],
- --(CH.sub.2).sub.x S(O).sub.r (CH.sub.2)y.sup.R 15,
- --(CH.sub.2).sub.x S(O).sub.r (CH.sub.2).sub.y COR.sup.15,
- --(CH.sub.2).sub.x S(O).sub.r (CH.sub.2).sub.y C(O)OR.sup.15,
- --(CH.sub.2).sub.x S(O).sub.r N[(CH.sub.2).sub.y R.sup.15 ] [(CH.sub.2).sub.y R.sup.16 ]
- --(CH.sub.2).sub.x N[(CH.sub.2).sub.y R.sup.15 ] [(CH.sub.2).sub.y R.sup.16 ],
- --(CH.sub.2).sub.x N[(CH.sub.2).sub.y R.sup.15 ] [CO(CH.sub.2).sub.y R.sup.16 ],
- --(CH.sub.2).sub.x N[(CH.sub.2).sub.y R.sup.15 ] [C(O)O(CH.sub.2).sub.y R.sup.16 ],
- --(CH.sub.2).sub.x N[(CH.sub.2).sub.y R.sup.15 ] CON[(CH.sub.2).sub.y R.sup.15 ] [(CH.sub.2).sub.y R.sup.16 ],
- --(CH.sub.2).sub.x N[(CH.sub.2).sub.y R.sup.15 ]CON[(CH.sub.2).sub.y R.sup.15 ]--[CO(CH.sub.2).sub.y R.sup.16 ],
- (CH.sub.2).sub.x N[(CH.sub.2).sub.y R.sup.15 ] [S(O).sub.r (CH.sub.2).sub.y R.sup.16 ];
- R.sup.15 and R.sup.16 are independently
- a) hydrogen,
- b) --(C.sub.1 -C.sub.8 alkyl,
- c) --(C.sub.1 -C.sub.4 alkyl)-aryl, where aryl is defined above,
- d) C.sub.5 -C.sub.7 cydoalkyl,
- e) phenyl, substituted by 0-3 R.sup.18,
- f) benzyl, substituted by 0-3 R.sup.18, or
- g) --(C.sub.1 -C.sub.4 alkoxy);
- R.sup.15 and R.sup.16 can be taken together to form a ring: ##STR165## R.sup.18 and R.sup.19 are independently H, halo (F, Cl, Br, I), C.sub.1 -C.sub.8 -alkyl, C.sub.3 -C.sub.8 cycloalkyl, C.sub.2 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -alkynyl, --(CH.sub.2).sub.w --OR.sup.8, --(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NC, --(CH.sub.2).sub.w NO.sub.2, --(CH.sub.2).sub.w CF.sub.3, --(CH.sub.2).sub.w S(O).sub.r R.sup.7, --(CH.sub.2).sub.w NR.sup.8 R.sup.9, --(CH.sub.2).sub.w COR.sup.8, --(CH.sub.2).sub.w CO.sub.2 R.sup.8, --(CH.sub.2).sub.w CONR.sup.8 R.sup.9, --(CH.sub.2).sub.w SO.sub.2 NH--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH.sub.2, --(CH.sub.2).sub.w SO.sub.2 NH--CO--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH--CO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --CH.sub.2).sub.w SO.sub.2 NH--(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 -(C.sub.1 -C.sub.6)-perfluoroalkyl, --(CH.sub.2).sub.w NHSO.sub.2 -phenyl, --(CH.sub.2).sub.w NHSO.sub.2 -perfluorophenyl, --(CH.sub.2).sub.w CN.sub.4 H, --O(C.dbd.O)--(C.sub.1 -C.sub.5 -alkyl), --O(CH.sub.2).sub.w CN, --NH(CH.sub.2).sub.w CN, --S(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -phenyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO.sub.2 (C.sub.1 -C.sub.6 -phenyl), or --O(C.dbd.O)phenyl;
- R18 and R19 can be taken together to form a methylenedioxy group;
- R.sup.20 and R.sup.20a are independently:
- (C.sub.1 -C.sub.8)alkyl, --(CH.sub.2).sub.u phenyl wherein the phenyl contains 0-3 substituents selected from R.sup.18, (C.sub.1 -C.sub.6)-perfluoroalkyl,or --(CH.sub.2).sub.r --D;
- m is 0 to 6;
- n is 1 to 2;
- p is 0 to 2;
- q is 0 to 4.
- r is 0 to 2;
- s is 0 to 3;
- t is 1 to 5;
- u is 0 to 5;
- w is 0 to 5;
- x is 0 to 6;
- y is 0 to 6;
- D is fur-2-yl, fur-3-yl, thiophen-2-yl, thiophen-3-yl, oxazol-2-yl, oxazol-4-yl, thiazol-2-yl, thiazol-4-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, pyrid-2-yl, pyrid-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrazin-2-yl, or tetrazoly;
- E is --CO--, --SO.sub.2 --, --CH.sub.2 -- or a single bond,
- F is --CO--;
- W is
- a) --O--,
- b) --S(O).sub.r --,
- c) --NR.sup.4 --,
- d) --NC(.dbd.O)R.sup.3 --,
- e) a bond, or
- f) --(CH.sub.2).sub.n --;
- or pharmaceutically acceptable salts thereof.
- 2. A compound of claim 1 wherein:
- Z is
- a) --(CH.sub.2).sub.m CONR.sup.8 --,
- b) --(CH.sub.2).sub.m CSNR.sup.8 --,
- c) --(CH.sub.2).sub.m SO.sub.2 NR.sup.8 --,
- R.sup.1 is
- a) heteroaryl, wherein heteroaryl is an unsubstituted, monosubstituted or disubstituted:
- i) quinolinyl,
- ii) isoquinolinyl,
- iii) benzopyranyl,
- iv) benzothiophenyl,
- v) benzofuranyl,
- vi) 5,6,7,8-tetrahydroquinolinyl,
- vii) 5,6,7,8-tetrahydroisoquinolinyl,
- and wherein the substituents are selected from the group consisting of halo (F, Cl, Br, I), --CN, C.sub.1 -C.sub.10 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.2 -C.sub.10 -alkenyl, C.sub.2 -C.sub.10 -alkynyl, R.sup.8, --OR.sup.8, --NO.sub.2, --CF.sub.3, --S(O).sub.r R.sup.7, --NR.sup.8 R.sup.9, --COR.sup.8, --CO.sub.2 R.sup.8, --CONR.sup.8 H, NR.sup.8 COR.sup.9, NR.sup.8 CO.sub.2 R.sup.9 ; ##STR166## e) wherein the ring ##STR167## represented by --J--K--L--M--Q-- is a group selected from: 1) --N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 2) --N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.N--,
- 3) --N--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--,
- 4) --N--C(R.sup.13).dbd.N--C(R.sup.13).dbd.N--,
- 5) --N--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.N--
- 6) --N--C(R.sup.13).dbd.N--N.dbd.N--,
- 7) --N--N.dbd.C(R.sup.13)--N.dbd.N--,
- 8) .dbd.C--O--C(R.sup.13).dbd.N--C(R.sup.13).dbd.,
- 9) --C.dbd.C(R.sup.13)--O--C(R.sup.13).dbd.N--,
- 10) .dbd.C--O--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.,
- 11) --C.dbd.C(R.sup.13)--C(R.sup.13).dbd.N--O--,
- 12) .dbd.C--C(R.sup.13).dbd.C(R.sup.13)--O--N.dbd.,
- 13) --C.dbd.C(R.sup.13)--O--N.dbd.C(R.sup.13)--,
- 14) .dbd.C--S--C(R.sup.13).dbd.N--C(R.sup.13).dbd.,
- 15) --C.dbd.C(R.sup.13)--S--C(R.sup.13).dbd.N--,
- 16) .dbd.C--S--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.,
- 17) --C.dbd.N--S--N.dbd.C(R.sup.13)--,
- 18) --C.dbd.N--S--C(R.sup.13).dbd.N--,
- 19) .dbd.C--S--N.dbd.C(R.sup.13)--N.dbd.,
- 20) .dbd.C--S--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.,
- 21) --C.dbd.C(R.sup.13)--S--C(R.sup.13).dbd.C(R.sup.13)--,
- 22) --C--O--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd., or
- 23) --C.dbd.C(R.sup.13)--O--C(R.sup.13).dbd.C(R.sup.13)--;
- f) wherein the ring ##STR168## represented by --C--W--R--T--U--V-- is a group selected from: 1) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 2) --C.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 3) --C.dbd.C(R.sup.13)--C(R.sup.13).dbd.N--C(R.sup.13).dbd.C(R.sup.13)--,
- 4) --C.dbd.N--N.dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 5) --C.dbd.C(R.sup.13)--N.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--,
- 6) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.N--,
- 7) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--,
- 8) --C.dbd.N--C(R.sup.13).dbd.N--C(R.sup.13).dbd.C(R.sup.13)--,
- 9) --C.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--,
- 10) --C.dbd.N--C(R.sup.13).dbd.N--N.dbd.C(R.sup.13)--,
- 11) --C.dbd.N--(R.sup.13).dbd.C(R.sup.13)--N.dbd.N--, or
- 12) --C.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--N.dbd.N--; ##STR169## is as defined above; ##STR170## is as defined above; ##STR171## wherein G is O, S, or NP (where P is an amine protecting group selected from the group consisting of: --R.sup.3, --C(.dbd.O)R.sup.3, --SO.sub.2 R.sup.3, --C(.dbd.O)OR.sup.3 ; ##STR172## wherein G is O, S, or NP (where P is an amine protecting group selected from the group consisting of: --R.sup.3, --C(.dbd.O)R.sup.3, --SO.sub.2 R.sup.3, --C(.dbd.O)OR.sup.3 ;
- R.sup.14 is:
- a) --H,
- b) --CF.sub.3
- c) --C.sub.1 -C.sub.4 alkyl,
- d) --(CH.sub.2).sub.q -aryl, wherein aryl is phenyl, biphenyl, naphthyl, or fluorenyl unsubstituted or substituted with one to three substituents selected from the group consisting of:
- halogen (F, Cl, Br, I),
- --CF.sub.3,
- --(C.sub.1 -C.sub.4 alkyl),
- --methylenedioxy,
- --(C.sub.1 -C.sub.4 alkoxy),
- --(CH.sub.2).sub.x N[(CH.sub.2).sub.y R.sup.15 ] [(CH.sub.2).sub.y R.sup.16 ];
- and all other required substituents of formula (I) are defined in claim 1.
- 3. A compound of claim 2 wherein
- Z is
- a) --(CH.sub.2).sub.m CONR.sup.8 --,
- b) --(CH.sub.2).sub.m CSNR.sup.8 --, or
- c) --(CH.sub.2).sub.m SO.sub.2 NR.sup.8 --;
- R.sup.1 is
- a) heteroaryl, wherein heteroaryl is an unsubstituted, monosubstituted or disubstituted:
- i) quinolinyl,
- ii) isoquinolinyl,
- iii) benzopyranyl,
- iv) benzothiophenyl,
- v) benzofuranyl,
- vi) 5,6,7,8-tetrahydroquinolinyl,
- vii) 5,6,7,8-tetrahydroisoquinolinyl,
- wherein the substituents are members selected from the group consisting of: halo (F, Cl, Br, I), --CN, C.sub.1 -C.sub.10 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.2 -C.sub.10 -alkenyl, C.sub.2 -C.sub.10 -alkynyl, R.sup.8, --OR.sup.8, --NO.sub.2, --CF.sub.3, --S(O).sub.r R.sup.7, --NR.sup.8 R.sup.9, --COR.sup.8, --CO.sub.2 R.sup.8, --CONR.sup.8 H, NR.sup.8 COR.sup.9, NR.sup.8 CO.sub.2 R.sup.9 ; ##STR173## wherein the ring represented by --J--K--L--M--Q-- is a group selected from:
- 1) --N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 2) --N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.N--,
- 3) --N--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--,
- 4) --N--C(R.sup.13).dbd.N--C(R.sup.13).dbd.N--,
- 5) --N--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.N--
- 6) --N--C(R.sup.13).dbd.N--N.dbd.N--,
- 7) --N--N.dbd.C(R.sup.13)--N.dbd.N--,
- 8) .dbd.C--O--C(R.sup.13).dbd.N--C(R.sup.13).dbd.,
- 9) --C.dbd.C(R.sup.13)--O--C(R.sup.13).dbd.N--,
- 10) .dbd.C--O--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.,
- 11) --C.dbd.C(R.sup.13)--C(R.sup.13).dbd.N--O--,
- 12) .dbd.C--C(R.sup.13).dbd.C(R.sup.13)--O--N.dbd.,
- 13) --C.dbd.C(R.sup.13)--O--N.dbd.C(R.sup.13)--,
- 14) .dbd.C--S--C(R.sup.13).dbd.N--C(R.sup.13).dbd.,
- 15) --C.dbd.C(R.sup.13)--S--C(R.sup.13).dbd.N--,
- 16) .dbd.C--S--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.,
- 17) .dbd.C--S--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.,
- 18) --C.dbd.C(R.sup.13)--S--C(R.sup.13).dbd.C(R.sup.13)--,
- 19) .dbd.C--O--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd., or
- 20) --C.dbd.C(R.sup.13)--O--C(R.sup.13).dbd.C(R.sup.13)--; ##STR174## wherein the ring represented by --C--W--R--T--U--V-- is a group selected from:
- 1) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 2) --C.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 3) --C.dbd.C(R.sup.13)--C(R.sup.13).dbd.N--C(R.sup.13).dbd.C(R.sup.13)--,
- 4) --C.dbd.N--N.dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 5) --C.dbd.C(R.sup.13)--N.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--,
- 6) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.N--,
- 7) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--,
- 8) --C.dbd.N--C(R.sup.13).dbd.N--C(R.sup.13).dbd.C(R.sup.13)--,
- 9) --C.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--,
- 10) --C.dbd.N--C(R.sup.13).dbd.N--N.dbd.C(R.sup.13)--,
- 11) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.N--, or
- 12) --C.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--N.dbd.N--; ##STR175## is as defined above; ##STR176## is as defined above; or ##STR177## wherein G is O, S, or NP (where P is an amine protecting group selected from the group consisting of: --R.sup.3, --C(.dbd.O)R.sup.3, --SO.sub.2 R.sup.3, --C(.dbd.O)OR.sup.3);
- R.sup.2 is
- a) --(C.sub.1 -C.sub.12 alkyl)--X,
- b) --(C.sub.2 -C.sub.12 alkenyl)--X, or ##STR178## X is a) halogen (F, Cl, Br, I),
- b) --CN,
- c) --NO.sub.2,
- d) --CF.sub.3,
- e) --NHR.sup.14
- f) --NHS(O).sub.r.sup.R 14,
- --NHC(NH)H,
- h) --NHC(NH)NHOH,
- i) --NHC(NH)NHCN,
- j) --NHC(NH)NHR.sup.14,
- k) --NHC(NH)NHCOR.sup.14,
- l) --C(NH)NHR.sup.14,
- m) --C(NH)NHCOR.sup.14,
- n) --C(O)NHR.sup.14,
- o) --C(O)NHC(O)R.sup.14,
- p) --C(O)OR.sup.14,
- q) --OR.sup.14,
- r) --OC(O)R.sup.14,
- s) --OC(O)OR.sup.14,
- t) --OC(O)NHR.sup.14,
- u) --OC(O)NHC(O)R.sup.14,
- v) --SC(.dbd.NH)NHR.sup.14, or
- w) --SC(.dbd.NH)NHC(.dbd.O)R.sup.14 ;
- R.sup.13 is
- H, halogen (F, Cl, Br, I), (C.sub.1 -C.sub.6)alkyl, --(CH.sub.2).sub.r --D, methylenedioxy, --(CH.sub.2).sub.w --OR.sup.8, --(CH.sub.2).sub.w NC, --(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NO.sub.2, --(CH.sub.2).sub.w S(O).sub.r R.sup.7, --(CH.sub.2).sub.w NR.sup.8 R.sup.9, --(CH.sub.2).sub.w COR.sup.8, --(CH.sub.2).sub.w CO.sub.2 R.sup.8, --(CH.sub.2).sub.w CONR.sup.8 R.sup.9, --(CH.sub.2).sub.w SO.sub.2 NH--(C.sub.1 -C.sub.5)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH.sub.2, --(CH.sub.2).sub.w SO.sub.2 NH--CO--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH--CO.sub.2 --(C.sub.1 1.varies.C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)perfluoroalkyl, --(CH.sub.2).sub.w NHSO.sub.2 -phenyl, --(CH.sub.2).sub.w NHSO.sub.2 -perfluorophenyl, --(CH.sub.2).sub.w CN.sub.4 H, --O(C.dbd.O)--(C.sub.1 -C.sub.5 -alkyl), --O(CH.sub.2).sub.w CN, --NH(CH.sub.2).sub.w CN, --S(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -phenyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO.sub.2 (C.sub.1 -C.sub.6 phenyl), --(CH.sub.2).sub.u phenyl wherein the phenyl contains 0-3 substituents selected from R.sup.18, or --O(C.dbd.O)phenyl wherein the phenyl contains 0-3 substituents selected from R.sup.18 ;
- R.sup.14 is
- a) --H,
- b) --CF.sub.3
- c) --C.sub.1 -C.sub.4 alkyl,
- d)--(CH.sub.2).sub.q -aryl, wherein aryl is phenyl, biphenyl, naphthyl, or fluorenyl unsubstituted or substituted with one to three substituents selected from the group consisting of:
- halogen (F, Cl, Br, I),
- --CF.sub.3,
- --(C.sub.1 -C.sub.4 alkyl),
- --methylenedioxy,
- --(C.sub.1 -C.sub.4 alkoxy), or
- --(CH.sub.2).sub.x N[(CH.sub.2).sub.y R.sup.15 ] [(CH.sub.2).sub.y R.sup.16 ];
- R.sup.18 and R.sup.19 are independently
- H, halo (F, Cl, Br, I), C.sub.1 -C.sub.6 -alkyl, --(CH.sub.2).sub.w --OR.sup.8, --(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NC, --(CH.sub.2).sub.w NO.sub.2, --(CH.sub.2).sub.w S(O).sub.r R.sup.7, --(CH.sub.2).sub.w NR.sup.8 R.sup.9, --(CH.sub.2).sub.w COR.sup.8, --(CH.sub.2).sub.w CO.sub.2 R.sup.8, --(CH.sub.2).sub.w CONR.sup.8 R.sup.9, --(CH.sub.2).sub.w SO.sub.2 NH--(C.sub.1 -C.sub.5)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH.sub.2, --(CH.sub.2).sub.w SO.sub.2 NH--CO--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH--CO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-perfluoroalkyl,--(CH.sub.2).sub.w NHSO.sub.2 -phenyl, --(CH.sub.2).sub.w NHSO.sub.2 -perfluorophenyl, --(CH.sub.2).sub.w CN.sub.4 H, --O(C.dbd.O)--(C.sub.1 -C.sub.5 -alkyl), --O(CH.sub.2).sub.w CN, --NH(CH.sub.2 ).sub.w CN, --S(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -phenyl), --(CH.sub.2).sub.w --NH--CO.sub.2 --(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -phenyl), or --O(C.dbd.O)phenyl;
- R18 and R19 can be taken together to form a methylenedioxy group;
- R.sup.20 and R.sup.20a are independently
- (C.sub.1 -C.sub.8)alkyl, --(CH.sub.2).sub.u phenyl wherein the phenyl contains 0-3
- substituents selected from R.sup.18, (C.sub.1 -C.sub.6)-perfluoroalkyl,or --(CH.sub.2).sub.r --D;
- D is fur-2-yl, fur-3-yl, thiophen-2-yl, thiophen-3-yl, oxazol-2-yl, oxazol-4-yl, thiazol-2-yl, thiazol-4-yl, pyrid-2-yl, pyrid-4-yl, pyrimidin-2-yl, or pyrimidin-4-yl;
- and all other required substituents of formula (I) are as in claim 2.
- 4. A compound of claim 3 wherein:
- Z is --(CH.sub.2).sub.m CONR.sup.8 --;
- R.sup.1 is
- a) heteroaryl, wherein heteroaryl is an unsubstituted, monosubstituted or disubstituted isoquinolinyl wherein the substituents are members selected from the group consisting of:
- halo (F, Cl, Br, I), --CN, C.sub.1 -C.sub.10 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.2 -C.sub.10 -alkenyl, C.sub.2 -C.sub.10 -alkynyl, R.sup.8, --OR.sup.8, --NO.sub.2, --CF.sub.3, --S(O).sub.r R.sup.7, --NR.sup.8 R.sup.9, --COR.sup.8, --CO.sub.2 R.sup.8, --CONR.sup.8 R.sup.9, NR.sup.8 CO.sub.2 R.sup.9, ##STR179## wherein the ring represented by --J--K--L--M--Q-- is a group selected from:
- 1) --N--C(R.sup.13).dbd.N--C(R.sup.13).dbd.N--,
- 2) --N--C(R.sup.13).dbd.C(R.sup.13)--N.dbd.N--,
- 3) --N--N.dbd.C(R.sup.13)--N.dbd.N--,
- 5) --N--C(R.sup.13).dbd.N--N.dbd.N--,
- 6) --C--S--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd., or
- 7) .dbd.C--O--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.; ##STR180## wherein the ring represented by --C--W--R--T--U--V-- is a group selected from:
- 1) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--
- 1) --C.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--C(R.sup.13).dbd.C(R.sup.13)--,
- 2) --C.dbd.C(R.sup.13)--C(R.sup.13).dbd.N--C(R.sup.13).dbd.C(R.sup.13)--,
- 3) --C.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--N.dbd.C(R.sup.13)--,
- 4) --C.dbd.N--C(R.sup.13).dbd.C(R.sup.13)--C(R.sup.13).dbd.N--, or
- 5) --C.dbd.N--C(R.sup.13).dbd.N--C(R.sup.13).dbd.C(R.sup.13)--; ##STR181## is as defined above; ##STR182## is as defined above; or ##STR183## wherein G is S; R.sup.2 is
- a) --(C.sub.1 -C.sub.12 alkyl)--X, or ##STR184## X is a) halogen (F, Cl, Br, I),
- b) --CN,
- c) --NHR.sup.14
- d) --NHC(NH)H,
- e) --NHC(NH)NHR.sup.14,
- f) --C(NH)NHR.sup.14,
- g) --OR.sup.14, or
- h) --SC(.dbd.NH)NHR.sup.14 ;
- R.sup.11 is H;
- R.sup.13 is
- H, halogen (F, Cl, Br, I), --(CH.sub.2).sub.w NO.sub.2, (C.sub.1 -C.sub.6)alkyl, --(CH.sub.2).sub.r --D, --(CH.sub.2).sub.w --OR.sup.8, --(CH.sub.2).sub.w CONR.sup.8 R.sup.9, --(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NC, --(CH.sub.2).sub.w COR.sup.8, --(CH.sub.2).sub.w CO.sub.2 R.sup.8, --(CH.sub.2).sub.w CO.sub.2 R.sup.3, --(CH.sub.2) .sub.w NR.sup.8 R.sup.3, --(CH.sub.2).sub.w S(O).sub.2 R.sup.7, --(CH.sub.2 wSO2NHCO--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO2-phenyl-(CH.sub.2).sub.w SO.sub.2 NH--(C.sub.1 -C.sub.5)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH.sub.2, --(CH.sub.2).sub.w SO.sub.2 NH--CO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-perfluoroalkyl, --(CH.sub.2).sub.w CN.sub.4 H, --O(C.dbd.O)--(C.sub.1 -C.sub.5 -alkyl), --O(CH.sub.2).sub.t CN, --NH(CH.sub.2).sub.t CN, --S(CH.sub.2).sub.t CN, --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -perfluoroalkyl), or --(CH.sub.2).sub.u phenyl wherein the phenyl contains 0-3 substituents selected from R.sup.18 ;
- R.sup.14 is --H;
- R.sup.18 and R.sup.19 are independently
- H, halo (F, Cl, Br, I), C.sub.1 -C.sub.6 -alkyl, --(CH.sub.2).sub.w --OR.sup.8, --(CH.sub.2).sub.w CN, --(CH.sub.2).sub.w NC, --(CH.sub.2).sub.w NO.sub.2, --(CH.sub.2).sub.w S(O).sub.r R.sup.7, --(CH.sub.2).sub.w NR.sup.8 R.sup.9, --(CH.sub.2).sub.w COR.sup.8, --(CH.sub.2).sub.w CO.sub.2 R.sup.8, --(CH.sub.2).sub.w CONR.sup.8 R.sup.9, --(CH.sub.2).sub.w SO.sub.2 NH--(C.sub.1 -C.sub.5)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH.sub.2, --(CH.sub.2).sub.w SO.sub.2 NH--CO--(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w SO.sub.2 NH--CO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)-alkyl, --(CH.sub.2).sub.w NHSO.sub.2 --(C.sub.1 -C.sub.6)perfluoroalkyl, --(CH.sub.2).sub.w NHSO.sub.2 -phenyl, --(CH.sub.2).sub.w NHSO.sub.2 -perfluorophenyl, --(CH.sub.2).sub.w CN.sub.4 H, --O(C.dbd.O)--(C.sub.1 -C.sub.5 -alkyl), --O(CH.sub.2).sub.t CN, --NH(CH.sub.2).sub.t CN, --S(CH.sub.2).sub.t CN, --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -perfluoroalkyl), --(CH.sub.2).sub.w NH--CO--(C.sub.1 -C.sub.6 -phenyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -alkyl), --(CH.sub.2).sub.w NH--CO.sub.2 --(C.sub.1 -C.sub.6 -phenyl), or --O(C.dbd.O)phenyl;
- R18 and R19 can be taken together to form a methylenedioxy group;
- R.sup.20 is selected from the group consisting of:
- (CH.sub.2).sub.r --D, or --(CH.sub.2).sub.u phenyl wherein the phenyl contains 0-3 substituents selected from R.sup.18 ;
- and all other required substituents of formula (I) are defined as in claim 3.
- 5. A compound of claim 4 selected from the group consisting of:
- [N.sup.1 -(4-phenylbenzoyl)-(R)-boroarginine, hydrochloride;
- N.sup.1 -(3-phenoxybenzoyl)-(R)-boroarginine, hydrochloride;
- N.sup.1 -(1-fluorenonyl)-(R)-boroarginine, hydrochloride
- N.sup.1 -(4-[1-butyl]benzoyl)-(R)-boroarginine, hydrochloride;
- N.sup.1 -(2-benzoylbenzoyl)-(R)-boroarginine, hydrochloride;]
- N.sup.1 -(5-phenyl-2-furoyl)-(R)-boroarginine, hydrochloride;
- N.sup.1 -(2-phenyl-4-isoquinoloyl)-(R)-boroarginine, hydrochloride;
- N.sup.1 -(2-methyl-4-phenylbenzoyl)-(R)-boroarginine, hydrochloride;
- N.sup.1 -[4-phenyl-2-nitrobenzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-phenyl-2-fluorobenzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-phenyl-2-aminobenzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-phenyl-2-(methylsulfonamido)benzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-phenyl-2-(cyanomethylamino)benzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-phenyl-2-(cyanomethyl)benzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-phenyl-2-(diethylamino)benzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-[2-(t-butylaminosulfonyl)phenyl]-2-methyl-benzoyl]boroArg, (+)pinanediol ester;
- N.sup.1 -[4-[2-(aminosulfonyl)phenyl]-2-methyl-benzoyl]boroArg, (+)pinanediol ester;
- N.sup.1 -[4-[2-(methoxycarbonylaminosulfonyl)phenyl]-2-methyl-benzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-[2-(t-butylaminosulfonyl)phenyl]benzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-[2-(t-butylaminosulfonyl)phenyl]benzoyl]boroArg-OH;
- N.sup.1 -[4-[2-(n-butoxycarbonylaminosulfonyl)phenyl]-2-methyl-benzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-[2-(diethylaminosulfonyl)phenyl]-2-methyl-benzoyl]boroArg, (+)pinanediol ester;
- N.sup.1 -[4-[2-(t-butylaminosulfonyl)phenyl]-2-fluorobenzoyl]boroArg, (+)pinanediol ester;
- N.sup.1 -[4-[2-(aminosulfonyl)phenyl]-2-fluoro-benzoyl]boroArg, (+)pinanediol ester;
- N.sup.1 -[4-[2-(methoxycarbonylaminosulfonyl)phenyl]-2-fluorobenzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -[4-[2-(t-butylaminosulfonyl)phenyl]-2-nitrobenzoyl]boroArg, (+)pinanediol ester;
- N.sup.1 -[4-[2-(aminosulfonyl)phenyl]-2-nitro-benzoyl]boroArg, (+)pinanediol ester;
- N.sup.1 -[4-[2-(methoxycarbonylaminosulfonyl)phenyl]-2-nitrobenzoyl]boroArg, (+)-pinanediol ester;
- N.sup.1 -(3-phenylbenzoyl)boroarg, (+)-pinanediol;
- N.sup.1 -[4-(3-BOCNHphenyl)2-methyl-benzoyl]boroarg, (+)-pinanediol;]
- N.sup.1 -(5-phenyl-2-furoyl)boroarg, (+)-pinanediol;
- N.sup.1 -(5-phenyl-2-thienyl)boroarg, (+)-pinanediol;
- N.sup.1 -[4-(3-aminophenyl)benzoyl]boroarg, (+)-pinanediol;
- N.sup.1 -(3-phenylbenzoyl)borolys, (+)-pinanediol;]
- N.sup.1 -(5-phenyl-2-furoyl )boroarg-OH;
- (R)-[5-amino-1-[[[5-(phenylmethyl)-1H -1,2,4-triazol -1-yl]acetyl]amino]-pentyl]boronic acid hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta., 6.beta.]]-(1,1-dimethylethyl) [3-[5-[[[4-[(amino-iminomethyl)amino]-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzo-dioxaborol-2-yl)butyl]amino]carbonyl]-2-thienyl]phenyl]carbamate hydrochloride;
- [3aS -[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-5-(phenyl-methyl)-3-(2H -tetrazol-5-ylmethyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-1-[2-[[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]amino]-2-oxoethyl]-5-(phenylmethyl)-1H -1,2,4-triazole-3-acetic acid hydrochloride 1:1; [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.beta.]]-1-[2-[[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]amino]-2-oxoethyl]-3-(phenylmethyl)-1H-1,2,4-triazole-5-acetic acid hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-methyl 1-[2-[[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-amino]-2-oxoethyl]-5-(phenylmethyl)-1H-1,2,4-triazole-3-acetate hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.,]]-methyl 1-[2-[[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-amino]-2-oxoethyl]-3-(phenylmethyl)-1H-1,2,4-triazole-5-acetate hydrochloride;
- [3aS [2(S*), 3a.alpha.,4.beta., 6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-3-phenyl-5-(phenyl-methyl)-1H -1,2,4-triazole-1-acetamide hydrochloride;
- (R)-[5-amino-1-[[[3-phenyl-5-(phenylmethyl)-1H-1,2,4-triazol-1-yl]acetyl]-amino]pentyl]boronic acid hydrochloride;
- [3aS-[2(S*),3.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-3-(3-nitro-phenyl)-5-(phenylmethyl)-1H -1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.alpha., 6.beta.,7a.alpha.]]-N-[4-[(aminoiminomethyl)-amino]-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)butyl]-3-(3-nitrophenyl)-5-(phenylmethyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.9 ]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-3,5-bis(phenyl-methyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a,4.beta.,6.beta.,7a.alpha.]]-N-[4-[(aminoiminomethyl)-amino]-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)butyl]-3,5-bis(phenylmethyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-3-(phenylmethyl)-1H-1,2,4-triazole-1-acetamide;
- (R)-[5-amino-1-[[[3-(phenylmethyl)-1H-1,2,4-triazol-1-yl]acetyl]amino]-pentyl]boronic acid hydrochloride;
- [3aS-[2(S*), 3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-5-methyl-3-(phenylmethyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(R*),3a.alpha.,4.beta.,6.beta.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-5-[(phenyl-methoxy)methyl]-3-(phenylmethyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-5-(cyanomethyl)-3-(phenylmethyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- 3aS-[2(S*), 3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-3-(phenylmethyl)-5-propyl-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta., 6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-5-phenyl-3-(phenylmethyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- (R)-[5-amino-1-[[[5-methyl-3-(phenylmethyl)-1H-1,2,4-triazol-1-yl]acetyl]-amino]pentyl]boronic acid hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-3-phenyl-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-5-methyl-3-phenyl-1H-1,2,4-triazole-1-acetamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)pentyl]-5-(2-phenyl-ethyl)-1H-1,2,4-triazole-1-acetamide;
- (R)-[5-amino-1-[[[5-(2-phenylethyl)-1H-1,2,4-triazol-1-yl]acetyl]amino]-pentyl]boronic acid hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-3,5-bis(2-phenyl-ethyl)-1H-1,2,4-triazole-1-acetamide hydrochloride;
- (R)-[5-amino-1-[[[3,5-bis(2-phenylethyl)-1H -1,2,4-triazol-1-yl]acetyl]amino]-pentyl]boronic acid hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-3-(2-phenylethyl)-1H-1,2,4-triazole-1-acetamide;
- (R)-[5-amino-1-[[[3-(2-phenylethyl)-1H-1,2,4-triazol-1-yl]acetyl]amino]-pentyl]boronic acid hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-3-(3-phenyl-propyl)-1H-1,2,4-triazole-1-acetamide;
- (R)-[5-amino-1-[[[5-(3-phenylpropyl)-1H-1,2,4-triazol-1-yl]acetyl]amino]-pentyl]boronic acid hydrochloride;
- (R)-[5-amino-1-[[[3-(3-phenylpropyl)-1H-1,2,4-triazol-1-yl]acetyl]amino]-pentyl]boronic acid hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-1,5-bis(phenyl-methyl)-1H -1,2,4-triazole-3-acetamide hydrochloride 2:8; (R)-[5-amino-1-[[[1,5-bis (phenylmethyl)-1H-1,2,4-triazol-3-yl]acetyl]amino]pentyl]boronic acid hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a, 5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-4-methyl-2-phenyl-5-pyrimidinecarboxamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimetyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-2,4-diphenyl-5-pyrimidinecarboxamide hydrochloride;
- [3aS-[2(S*),3a.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[4-[(amimoiminomethyl)amino]-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl)-butyl]-4-methyl-2-phenyl-5-pyrimidinecarboxamide hydrochloride;
- [3aS-[2(S*),3.alpha.,4.beta.,6.beta.,7a.alpha.]]-N-[5-amino-1-(hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl) pentyl]-6-phenyl-3-pyridinecarboxamide hydrochloride and
- (R)-[5-amino-1-[[(6-phenyl-3-pyridinyl) carbonyl]amino]pentyl]boronic acid dihydrochloride.
- 6. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of any one of claims 1 through 5.
- 7. A method of treating a physiological disorder in a warm blooded animal catalyzed by trypsin-like enzymes comprising administering to an animal in need of such treatment an effective amount of a compound of any one of claims 1 through 5.
CROSS-REFERENCE TO EARLIER FILED APPLICATIONS
This application is a continuation-in-part of U.S. patent application Ser. No. 08/348/029, filed Dec. 1, 1994, still pending which is a continuation-in-part of U.S. patent application Ser. No. 08/318/029, filed Oct. 4, 1994, now abandoned which is a continuation-in-part of U.S. patent application Ser. No. 08/036/377, filed Mar. 24, 1993 now abandoned.
Foreign Referenced Citations (3)
Number |
Date |
Country |
0293881A2 |
Jan 1988 |
EPX |
2469388 |
Apr 1988 |
EPX |
0471651A2 |
Sep 1991 |
EPX |
Non-Patent Literature Citations (1)
Entry |
CA 121-206023K Preparation of . . . Elastase Inhibitors. Bernstein et al., p. 1246, 1994. |
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
348029 |
Dec 1994 |
|
Parent |
318029 |
Oct 1994 |
|
Parent |
36377 |
Mar 1993 |
|